Valorisations sectorielles Halozyme Therapeutics, Inc.
Actions
HALO
US40637H1095
Produits pharmaceutiques
|
Marché Fermé -
Nasdaq
22:00:00 22/09/2026
|
Varia. 5j. | Varia. 1 janv. | ||
| 115,13 USD | +3,30% |
|
+8,36% | +71,07% |
Principaux concurrents
Ajouter à une liste 0 sélectionné | PER (N) | Price to Book (N) | PEG (N) | VE / CA (N) | VE / EBITDA (N) | VE / EBIT (N) | Rendement du dividende (N) | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|
| 15.98x | 18.63x | 0.09x | 7.77x | 11.92x | 13.1x | - | 13,07 Md | ||
| 109.79x | 7.68x | -1.35x | 6.11x | 25.92x | 34.19x | 2,26% | 372 Md | ||
| 22.54x | 1.9x | -14.4x | 3.06x | 10.68x | 17.75x | 1,76% | 66,24 Md | ||
| 14.4x | 1.26x | 0.64x | 1.79x | 6.09x | 7.06x | 3,08% | 7,51 Md | ||
| 18.16x | 5.28x | 0.75x | 5.65x | 15.09x | 15.62x | -.--% | 4,44 Md | ||
| 36.01x | 2.41x | -1.82x | 2.36x | 26.78x | 42x | 0,77% | 4,13 Md | ||
| 36.49x | - | 0.4x | 5.69x | 16.66x | 29.06x | - | 3,18 Md | ||
| -218.75x | - | 3.1x | - | - | - | -.--% | 2,54 Md | ||
| 52.5x | - | -0.07x | - | - | - | - | 1,63 Md | ||
| -82.91x | 2.01x | 1.24x | - | - | - | - | 1,13 Md | ||
| 12.95x | 0.84x | -1.93x | 1.1x | 7.96x | 24.66x | 4,24% | 1,05 Md | ||
| 43.04x | 6.75x | -1.12x | 14.29x | 30x | 35.29x | - | 1,02 Md | ||
| Moyenne | 5,02x | 5,19x | -1,20x | 5,31x | 16,79x | 24,30x | 1,73% | 39,86 Md | |
| Moyenne pondérée par Capi. | 88,92x | 6,97x | -3,03x | 5,63x | 22,90x | 30,72x | 2,16% |
- Bourse
- Actions
- Action HALO
- Secteur Halozyme Therapeutics, Inc.
- Valorisations sectorielles
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
















